Cargando…

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (WHO) and GOLD 2023 have developed an updated...

Descripción completa

Detalles Bibliográficos
Autor principal:	Parums, Dinah V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552569/ https://www.ncbi.nlm.nih.gov/pubmed/37777859 http://dx.doi.org/10.12659/MSM.942672

Ejemplares similares

Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Artificial Intelligence (AI) in Clinical Medicine and the 2020 CONSORT-AI Study Guidelines
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Current Status of Non-Endemic Global Infections with the Monkeypox Virus
por: Parums, Dinah V.
Publicado: (2022)

Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care
por: Parums, Dinah V.
Publicado: (2021)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
por: Terry, Paul D., et al.
Publicado: (2023)

Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate Hepatitis C
por: Parums, Dinah V.
Publicado: (2023)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Editorial: Maternal SARS-CoV-2 Infection and Pregnancy Outcomes from Current Global Study Data
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread
por: Parums, Dinah V.
Publicado: (2023)

Editorial: Global Surveillance of Highly Pathogenic Avian Influenza Viruses in Poultry, Wild Birds, and Mammals to Prevent a Human Influenza Pandemic
por: Parums, Dinah V.
Publicado: (2023)

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2023)

Editorial: Registries and Population Databases in Clinical Research and Practice
por: Parums, Dinah V.
Publicado: (2021)

Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
por: Parums, Dinah V.
Publicado: (2021)

Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

Retracted: Editorial: mRNA Vaccines and Immunotherapy in Oncology: A new Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

Editorial: The Increasing Relevance of Case Reports in Medical Education and Clinical Practice – and How to Write Them
por: Parums, Dinah V.
Publicado: (2023)

Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2022)

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
por: Parums, Dinah V.
Publicado: (2022)

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
por: Parums, Dinah V.
Publicado: (2023)

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients
por: Parums, Dinah V.
Publicado: (2022)

Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030
por: Parums, Dinah V.
Publicado: (2023)

Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?
por: Parums, Dinah V.
Publicado: (2021)

Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

Editorial: First Regulatory Approval for Allogeneic Pancreatic Islet Beta Cell Infusion for Adult Patients with Type 1 Diabetes Mellitus
por: Parums, Dinah V.
Publicado: (2023)

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
por: Parums, Dinah V.
Publicado: (2023)

Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
por: Parums, Dinah V.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvjvkcddknoadaffkqisj6jinu